Matthew P. Patricelli

机构：Vividion Therapeutics (United States) · ORCID：0000-0002-7829-7065

发表论文 112 篇 · 总被引 9676 次 · h-index 34

代表论文

Chemoproteomic discovery of a covalent allosteric inhibitor of WRN helicase (2024 · Nature · 被引 119)
A Covalent Allosteric Molecular Glue Suppresses NRF2-Dependent Cancer Growth (2025 · Cancer Discovery · 被引 19)
Suppression of NRF2-dependent cancer growth by a covalent allosteric molecular glue (2024 · bioRxiv (Cold Spring Harbor Laboratory) · 被引 13)
Covalent inhibitors of the PI3Kα RAS binding domain impair tumor growth driven by RAS and HER2 (2025 · Science · 被引 12)
Identification of VVD-214/RO7589831, a Clinical-Stage, Covalent Allosteric Inhibitor of WRN Helicase for the Treatment of MSI-High Cancers (2025 · Journal of Medicinal Chemistry · 被引 9)
Normalizing Covalent Potency for Electrophilicity with Ligand Reactivity Efficiency (2026 · Journal of Medicinal Chemistry · 被引 2)